Public contracts of the Alpes-de-Haute-Provence département · 2026

Vaccin anti meningocoque du

€90k

framework agreement: a maximum envelope for orders over 3 years, not spending — what was paid on it is not published

Signed on 13 February 2026 · running until about February 2029 · 3 yrs

Ongoing13 Feb 2029

That is at most ~€30k a year on average: a maximum too.

Company selected

PfizerCommerce de gros (commerce interentreprises) de produits pharmaceutiques · registered office Paris (75014) · headcount 1,000 to 1,999 employees · SIREN 433623550

A contract awarded to 2 holders; above, the main holder. With it: Sanofi Winthrop Industrie. The amount is the whole contract’s: the DECP does not publish each holder’s share.

The competition

2 bids received

Median for this procedure in 2026: 3 bids, across 8946 comparable contracts. Open tender · awarded to 2 companies

Open data gives the contract holder and the number of bids. The identity of unsuccessful bidders is not published.

Number 57 by amount of the 83 contracts the Alpes-de-Haute-Provence département published for 2026.

Other contracts of Pfizer in Alpes-de-Haute-Provence

Vaccin contre pneumocoque 13 valences2020 · maximum over 2 years48€k

Contract details (procedure, price, amendments, lots)

Procedure : Appel d'offres ouvert

Framework agreement : yes: orders follow, the amount is a ceiling

Price : Unitaire

Published amendments : none

Environmental considerations : Clause environnementale

Contracts above €40,000 excluding VAT, as declared when they are awarded (DECP): contract amounts, not payments. Smaller contracts are not published; obviously wrong amounts are set aside.